News about Global Pharma

Dr Reddy's Lab launches Avigan for COVID-19 treatment

Dr Reddy's Lab launches Avigan for COVID-19 treatment

Dr Reddy's Laboratories Ltd announced the launch of Avigan (favipiravir) 200 mg tablets in India for the treatment of patients with mild to moderate COVID-19 disease

Global Pharma | 19/08/2020 | By Darshana 100

Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore

Aurobindo Pharma Q1 net profit rises by 22.8% to Rs. 780.6 crore

Aurobindo Pharma registered a 22.8 per cent year-on-year rise in net profit at Rs. 780.6 crore for the first quarter ended June 2020

Global Pharma | 13/08/2020 | By Darshana

FDA Posts Interim Results from Required Essure Postmarket Surveillance Study

FDA Posts Interim Results from Required Essure Postmarket Surveillance Study

?Although Essure is no longer available for implantation in the U.S., the FDA remains committed to evaluating long-term safety information in women who have received the device, including data from an FDA-required postmarket surveillance study.?

Global Pharma | 10/07/2020 | By Darshana

FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients

FDA issues warning letters to two breast implant manufacturers as part of ongoing efforts to protect patients

Today, the U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with various regulatory requirements

Global Pharma | 15/05/2020 | By Darshana 121

Merck?s foundational CRISPR-Cas9 technology receives US patnet

Merck?s foundational CRISPR-Cas9 technology receives US patnet

Merck, a leading science and technology company, announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States

Global Pharma | 12/05/2020 | By Darshana 118

FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients

FDA Authorizes First Antigen Test to Help in the Rapid Detection of the Virus that Causes COVID-19 in Patients

The U.S. Food and Drug Administration has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic

Global Pharma | 10/05/2020 | By Darshana 106

FDA Continues to Combat Fraudulent COVID-19 Medical Products

FDA Continues to Combat Fraudulent COVID-19 Medical Products

Today, the U.S. Food and Drug Administration is providing an update on the agency?s efforts to combat the extremely concerning actions by companies and individuals that are exploiting or taking advantage of widespread fear among consumers during the COVID-19 pandemic

Global Pharma | 08/05/2020 | By Darshana

Cleveland Clinic establishes center for global and emerging pathogens research

Cleveland Clinic establishes center for global and emerging pathogens research

Cleveland Clinic is establishing the Center for Global and Emerging Pathogens Research to broaden understanding of emerging pathogens ? ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) ? and to expedite critically needed treatments and vaccines

Global Pharma | 04/05/2020 | By Darshana 124

Revive Therapeutics gets US FDA recommendation tostart phase 3 trial of Bucillamine to treat COVID-19

Revive Therapeutics gets US FDA recommendation tostart phase 3 trial of Bucillamine to treat COVID-19

Revive Therapeutics, a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced that it has received positive feedback from the US Food and Drug Administration (FDA) in response to the company?s Pre-Investigational New Drug (pre-IND) meeting

Global Pharma | 25/04/2020 | By Darshana 530

WHO issue new guidance on use of ferritin concentrations to assess iron deficiency and protect brain development

WHO issue new guidance on use of ferritin concentrations to assess iron deficiency and protect brain development

Detecting iron deficiency early during pregnancy and in young children is crucial. Iron deficiency in children under two years of age can have significant and irreversible effects on brain development. This can lead to negative consequences on learning and school performance later in life

Global Pharma | 22/04/2020 | By Darshana 105

 
 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology